CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 139 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,868,000 | -55.5% | 95,000 | -60.4% | 0.69% | -54.6% |
| Q2 2022 | $4,198,000 | +185.2% | 240,000 | +166.7% | 1.53% | +258.7% |
| Q1 2022 | $1,472,000 | -5.0% | 90,000 | -5.3% | 0.43% | +11.2% |
| Q4 2021 | $1,549,000 | -64.2% | 95,000 | -65.2% | 0.38% | -33.0% |
| Q4 2020 | $4,329,000 | – | 272,949 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |